FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, and represents a sustained release solid therapeutic agent containing a combination of praziquantel with emodepside, polyvinylpyrrolidone and/or a polyvinylpyrrolidone derivative in an amount of 10 to 50 wt %, polyvinylpyrrolidone and/or the polyvinylpyrrolidone derivative is a mixture of one short-chain polyvinylpyrrolidone and one polyvinylpyrrolidone or the polyvinylpyrrolidone derivative with longer chains, and at least one excipient in an amount of 5 to 80 wt %.
EFFECT: sustained release of active substances and no lump formation in the gastrointestinal tract if two or more tablets taken.
4 cl, 7 ex, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
ENDOPARASITICIDAL PREPARATIONS | 2001 |
|
RU2292905C2 |
PREPARATIONS CONTAINING AMORPHOUS EMODEPSIDE | 2012 |
|
RU2651761C2 |
COMPOSITIONS CONTAINING AMORPHOUS EMODEPSID | 2012 |
|
RU2761529C2 |
ANTHELMINTIC AGENTS COMBINATIONS AND METHODS FOR USE THEREOF | 2016 |
|
RU2717545C2 |
ENDOPARASITICIDAL DRUG | 2006 |
|
RU2417101C2 |
TABLETS WITH IMPROVED INTAKE AND GOOD STORAGE STABILITY | 2013 |
|
RU2693005C2 |
TABLETS WITH IMPROVED INTAKE AND GOOD STORAGE STABILITY | 2013 |
|
RU2799052C1 |
NIFURTIMOX FOR TREATING DISEASES CAUSED BY TRICHOMONADIDA | 2009 |
|
RU2538712C2 |
NEW ALTERNATIVE FOR GIARDIASIS CONTROL | 2009 |
|
RU2538713C9 |
CRYSTALLINE MODIFICATION OF CYCLIC DEPSIPEPTIDE OF IMPROVED ACTIVITY | 2002 |
|
RU2300390C2 |
Authors
Dates
2015-04-20—Published
2009-04-23—Filed